Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Konstantina Soulele"'
Autor:
Konstantina Soulele, Panos Macheras
Publikováno v:
Oral Drug Delivery for Modified Release Formulations. :391-408
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8b9f8f0f96b603c3b343f13eb109b33
https://doi.org/10.1002/9781119772729.ch22
https://doi.org/10.1002/9781119772729.ch22
Autor:
Panos Theodosiadis, Lida Kalantzi, Antonios Margaritis, Ioannis Halkiadakis, Konstantina Soulele, Dimitrios Koufakis, Evgenia Kanonidou, Anastasios Konstas, Constantinos D Georgakopoulos, Vasiliki Dimera, Michael Lygeros, Elias Zintzaras
Publikováno v:
Medical Hypothesis, Discovery & Innovation in Ophthalmology. 9
Background: This study aimed to evaluate the non-inferiority and safety of a newly developed preservative-free (PF) multi-dose latanoprost/timolol ophthalmic solution, compared with the benzalkonium chloride (BAK)-preserved fixed combination, in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f6814f84cba20ab86cba9c42e05037b
https://doi.org/10.51329/mehdiophthal1411
https://doi.org/10.51329/mehdiophthal1411
Autor:
Antonios Margaritis, Vasiliki Dimera, Constantinos D Georgakopoulos, Panos Theodosiadis, Evgenia Kanonidou, Konstantina Soulele, Lida Kalantzi, Dimitrios Koufakis, Elias Zintzaras, Anastasios Konstas, Ioannis Halkiadakis
Publikováno v:
Medical Hypothesis, Discovery & Innovation in Ophthalmology. 9
Background: The aim of this study was to test the non-inferiority of preservative-free (PF) latanoprost 50 μg/mL multi-dose ophthalmic solution versus the marketed benzalkonium chloride (BAK)-preserved latanoprost 50 μg/mL ophthalmic solution in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93479e62fc08135f84cf08c804b07a1
https://doi.org/10.51329/mehdiophthal1413
https://doi.org/10.51329/mehdiophthal1413
Autor:
Konstantina Soulele, Vangelis Karalis
Publikováno v:
Xenobiotica. 49:446-456
Ezetimibe is a potent cholesterol absorption inhibitor, with an erratic pharmacokinetic (PK) profile, attributed to an extensive enterohepatic recirculation (EHC). The aim of this study was to develop a population PK model able to adequately characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c91a62e1efe6133698ac4c2fe406fbb
https://doi.org/10.1080/00498254.2018.1463117
https://doi.org/10.1080/00498254.2018.1463117
Publikováno v:
Biopharmaceutics & Drug Disposition. 38:407-419
Salmeterol (SAL) is a long-acting β2-adrenergic agonist, which is widely used in the therapy of asthma. The aim of this study was to investigate the pharmacokinetics (PK) of inhaled salmeterol in asthma patients using two different dry powder inhale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c78d90992df10aadcfc4481a6cb4d1
https://doi.org/10.1002/bdd.2077
https://doi.org/10.1002/bdd.2077
Autor:
Vangelis Karalis, Konstantina Soulele
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 128
Ezetimibe (EZE) is an extensively used antihyperlipidemic drug with an important cholesterol lowering activity. It undergoes extensive first-pass metabolism to form its active glucuronide metabolite (EZEG). Both drugs exhibit complex pharmacokinetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d409a65359e4550fd67b78db20ac8b6
https://pubmed.ncbi.nlm.nih.gov/30465817
https://pubmed.ncbi.nlm.nih.gov/30465817
Publikováno v:
European Journal of Pharmaceutical Sciences. 80:33-42
The combination of fluticasone propionate (FLP) and salmeterol (SAL) is often used in clinical practice for the treatment of pulmonary disorders. The purpose of this study was to explore the pharmacokinetics (PK) of inhaled FLP and SAL, after concomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19035a7fc78c4dd14d3622e78707f398
https://doi.org/10.1016/j.ejps.2015.08.009
https://doi.org/10.1016/j.ejps.2015.08.009
Publikováno v:
Pulmonary pharmacologytherapeutics. 48
Dry powder inhalers containing the budesonide/formoterol combination have currently a well-established position among other inhaled products. Even though their efficacy mainly depends on the local concentrations of the drug they deliver within the lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fdfbd73998a4cecece3f56622a920b
https://pubmed.ncbi.nlm.nih.gov/29223508
https://pubmed.ncbi.nlm.nih.gov/29223508
Autor:
Konstantina Soulele, Panos Macheras
Publikováno v:
International Journal of Pharmaceutics. 492:344-345
In the case of pediatric medicinal products the selection of an appropriate and palatable liquid dosage form can make the difference between treatment success and failure. Since the recent adoption of Pediatric Regulations in the U.S. and E.U., there
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::025e02276325da72331f2094078d08e7
https://doi.org/10.1016/j.ijpharm.2015.05.015
https://doi.org/10.1016/j.ijpharm.2015.05.015